Case number 1:18-cv-00101
Takeda Pharmaceuticals U.S.A., Inc. v. Dr. Reddys Laboratories, Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 4, 2018 | 12 | Main Document (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,906,519; 7,935,731; 8,093,298; 7,964,648; 8,093,297; US 7,619,004; US 7,601,758; US 7,820,681; US 7,915,269; US 7,964,647; US 7,981,938; US 8,093,296; US 8,097,655; US 8,415,395; US 8,415,396; US 8,440,721; US 8,440,722. (Attachments: # (1) Order)(nms) |
| Jun 4, 2018 | 12 | Order (2) |
| Jun 4, 2018 | 12 | Patent/Trademark Report to Commissioner (2) |
| Jun 4, 2018 | 11 | Order (2) Docket Text: SO ORDERED Granting [10] Stipulation and Order of Dismissal without prejudice (***Civil Case Terminated). Signed by Judge Richard G. Andrews on 6/4/2018. (nms) |
| Jun 4, 2018 | 10 | Stipulation of Dismissal (2) Docket Text: STIPULATION of Dismissal without Prejudice and Proposed Order, by Takeda Pharmaceuticals U.S.A., Inc.. (Bourke, Mary) Modified on 6/4/2018 (nms). |
| Apr 24, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [9] Stipulation and Order to Stay Action Pending Regulatory Review of Settlement (see Stipulation for further details). Signed by Judge Richard G. Andrews on 4/23/2018. (nms) |
| Apr 23, 2018 | 9 | Stipulation (3) Docket Text: STIPULATION and [Proposed] Order to Stay Action Pending Regulatory Review of Settlement by Takeda Pharmaceuticals U.S.A., Inc.. (Attaway, Daniel) |
| Apr 13, 2018 | 8 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to answer, move or otherwise respond to the Complaint to May 1, 2018 - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Attaway, Daniel) |
| Apr 13, 2018 | N/A | SO ORDERED (0) |
| Mar 29, 2018 | 7 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Answer, Move, or Otherwise Respond to the Complaint to April 17, 2018 - filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd.. (Ormerod, Eve) Modified on 3/29/2018 (nms). |
| Mar 29, 2018 | N/A | SO ORDERED (0) |
| Feb 6, 2018 | 6 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Takeda Pharmaceuticals U.S.A., Inc.: For Dr. Reddys Laboratories, Inc. waiver sent on 1/30/2018, answer due 4/2/2018; Dr. Reddys Laboratories, Ltd. waiver sent on 1/30/2018, answer due 4/2/2018. (Attaway, Daniel) |
| Jan 24, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Jan 17, 2018 | 1 | Complaint (37) |
| Jan 17, 2018 | 1 | Exhibit M (35) |
| Jan 17, 2018 | 1 | Exhibit N (19) |
| Jan 17, 2018 | 1 | Exhibit O (19) |
| Jan 17, 2018 | 1 | Exhibit P (31) |
| Jan 17, 2018 | 1 | Exhibit Q (31) |
| Jan 17, 2018 | 1 | Exhibit R (27) |
| Jan 17, 2018 | 1 | Exhibit S (26) |
| Jan 17, 2018 | 1 | Exhibit T (7) |
| Jan 17, 2018 | 1 | Exhibit U (4) |
| Jan 17, 2018 | 1 | Civil Cover Sheet (2) |
| Jan 17, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) |
| Jan 17, 2018 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 12/11/2017. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 6/11/2020. (nmg) |
| Jan 17, 2018 | 4 | Patent/Trademark Report to Commissioner (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,906,519; 7,935,731; 8,093,298; 7,964,648; 8,093,297; US 7,619,004; US 7,601,758; US 7,820,681; US 7,915,269; US 7,964,647; US 7,981,938; US 8,093,296; US 8,097,655; US 8,415,395; US 8,415,396; US 8,440,721; US 8,440,722. (nmg) (Main Document 4 replaced on 1/18/2018) (nmg). |
| Jan 17, 2018 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Takeda Pharmaceutical Company Limited, Corporate Parent Takeda Pharmaceuticals International AG for Takeda Pharmaceuticals U.S.A., Inc. filed by Takeda Pharmaceuticals U.S.A., Inc. (nmg) |
| Jan 17, 2018 | 1 | Exhibit L (36) |
| Jan 17, 2018 | 1 | Exhibit K (28) |
| Jan 17, 2018 | 1 | Exhibit J (26) |
| Jan 17, 2018 | 1 | Exhibit I (16) |
| Jan 17, 2018 | 1 | Exhibit H (16) |
| Jan 17, 2018 | 1 | Exhibit G (27) |
| Jan 17, 2018 | 1 | Exhibit F (29) |
| Jan 17, 2018 | 1 | Exhibit E (19) |
| Jan 17, 2018 | 1 | Exhibit D (16) |
| Jan 17, 2018 | 1 | Exhibit C (23) |
| Jan 17, 2018 | 1 | Exhibit B (16) |
| Jan 17, 2018 | 1 | Exhibit A (25) |
| Jan 17, 2018 | 1 | Main Document (37) Docket Text: COMPLAINT for PATENT INFRINGEMENT filed against Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2303005.) - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Civil Cover Sheet)(nmg) |
| Jan 17, 2018 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Dr. Reddys Laboratories, Inc. on 1/17/2018; Dr. Reddys Laboratories, Ltd. on 1/17/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmg) |
| Jan 17, 2018 | 1 | Complaint* (1) |
